{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T04:23:45Z","timestamp":1780892625816,"version":"3.54.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2012,4,10]],"date-time":"2012-04-10T00:00:00Z","timestamp":1334016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Parathyroid hormone (PTH) has variable actions on bone. Chronically increased PTH is catabolic and leads to osteoporosis; yet intermittent administration is anabolic and increases bone mass. PTH deficiency is associated with decreased bone remodeling and increased bone mass. However, the effects of PTH replacement therapy on bone in hypoparathyroidism are not well known. We discontinued calcitriol therapy and treated 5 hypoparathyroid subjects (2 adults and 3 adolescents) with synthetic human PTH 1-34 (hPTH 1-34), injected two to three times daily for 18 months, with doses individualized to maintain serum calcium at 1.9 to 2.25\u2009mmol\/L. Biochemical markers and bone mineral density (BMD) were assessed every 6 months; iliac-crest biopsies were performed before and after 1 year of treatment. hPTH 1-34 therapy significantly increased bone markers to supranormal levels. Histomorphometry revealed that treatment dramatically increased cancellous bone volume and trabecular number and decreased trabecular separation. Changes in trabecular width were variable, suggesting that the increase in trabecular number was due to the observed intratrabecular tunneling. Cortical width remained unchanged; however, hPTH 1-34 treatment increased cortical porosity. Cancellous bone remodeling was also stimulated, inducing significant changes in osteoid, mineralizing surface, and bone formation rate. Similar changes were seen in endocortical and intracortical remodeling. BMD Z-scores were unchanged at the spine and femoral neck. Total hip Z-scores increased; however, total body BMD Z-scores decreased during the first 6 months of treatment and then stabilized, remaining significantly decreased compared to baseline. Radial Z-scores also decreased with treatment; this was most pronounced in the growing adolescent. Daily hPTH 1-34 therapy for hypoparathyroidism stimulated bone turnover, increased bone volume, and altered bone structure in the iliac crest. These findings suggest that treatment with hPTH 1-34 in hypoparathyroid adults and adolescents has varying effects in the different skeletal compartments, leading to an increase in trabecular bone and an apparent trabecularization of cortical bone. Published 2012 American Society for Bone and Mineral Research. This article is a US Government work and, as such, is in the public domain in the United States of America.<\/jats:p>","DOI":"10.1002\/jbmr.1627","type":"journal-article","created":{"date-parts":[[2012,4,10]],"date-time":"2012-04-10T14:30:32Z","timestamp":1334068232000},"page":"1811-1820","source":"Crossref","is-referenced-by-count":74,"title":["Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure"],"prefix":"10.1093","volume":"27","author":[{"given":"Rachel I","family":"Gafni","sequence":"first","affiliation":[{"name":"Skeletal Clinical Studies Unit, Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime S","family":"Brahim","sequence":"additional","affiliation":[{"name":"Division of Oral-Maxillofacial Surgery, University of Maryland Medical Center, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiota","family":"Andreopoulou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisan","family":"Bhattacharyya","sequence":"additional","affiliation":[{"name":"Skeletal Clinical Studies Unit, Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn H","family":"Kelly","sequence":"additional","affiliation":[{"name":"Skeletal Clinical Studies Unit, Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth A","family":"Brillante","sequence":"additional","affiliation":[{"name":"Skeletal Clinical Studies Unit, Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhou","sequence":"additional","affiliation":[{"name":"Regional Bone Center, Helen Hayes Hospital, West Haverstraw, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W","family":"Dempster","sequence":"additional","affiliation":[{"name":"Regional Bone Center, Helen Hayes Hospital, West Haverstraw, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T","family":"Collins","sequence":"additional","affiliation":[{"name":"Skeletal Clinical Studies Unit, Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,4,10]]},"reference":[{"issue":"12","key":"2024020318273840300_bib1","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1359\/jbmr.080803","article-title":"Dynamic and structural properties of the skeleton in hypoparathyroidism","volume":"23","author":"Rubin","year":"2008","journal-title":"J Bone Miner Res."},{"issue":"2","key":"2024020318273840300_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/8756-3282(95)00443-2","article-title":"Bone histomorphometry in hypoparathyroid patients treated with vitamin D","volume":"18","author":"Langdahl","year":"1996","journal-title":"Bone."},{"issue":"8","key":"2024020318273840300_bib3","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.1996.03540080053029","article-title":"Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism","volume":"276","author":"Winer","year":"1996","journal-title":"JAMA."},{"issue":"9","key":"2024020318273840300_bib4","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/jc.2002-021736","article-title":"Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium","volume":"88","author":"Winer","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2024020318273840300_bib5","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/jbmr.452","article-title":"PTH(1\u201384) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism","volume":"26","author":"Rubin","year":"2011","journal-title":"J Bone Miner Res."},{"issue":"11","key":"2024020318273840300_bib6","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00198-009-1149-x","article-title":"Therapy of hypoparathyroidism with intact parathyroid hormone","volume":"21","author":"Rubin","year":"2010","journal-title":"Osteoporos Int."},{"issue":"10","key":"2024020318273840300_bib7","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/jbmr.470","article-title":"The effect of adding PTH(1\u201384) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study","volume":"26","author":"Sikjaer","year":"2011","journal-title":"J Bone Miner Res."},{"issue":"4","key":"2024020318273840300_bib8","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/jbmr.1493","article-title":"Changes in 3-dimensional bone structure indices in hypoparathyroid patients treated with PTH(1\u201384): a randomized controlled study","volume":"27","author":"Sikjaer","year":"2012","journal-title":"J Bone Miner Res."},{"issue":"6","key":"2024020318273840300_bib9","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1210\/jc.2006-2553","article-title":"The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race","volume":"92","author":"Kalkwarf","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020318273840300_bib10","first-page":"491","volume-title":"Principles and Practice of Endocrinology and Metabolism","author":"Dempster","year":"1995","edition":"2nd ed"},{"issue":"6","key":"2024020318273840300_bib11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res."},{"issue":"2","key":"2024020318273840300_bib12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jbmr.5650030203","article-title":"Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females","volume":"3","author":"Recker","year":"1988","journal-title":"J Bone Miner Res."},{"issue":"6","key":"2024020318273840300_bib13","first-page":"2264","article-title":"Changes in quantitative bone histomorphometry in aging healthy men","volume":"81","author":"Clarke","year":"1996","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2024020318273840300_bib14","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1359\/jbmr.1997.12.6.948","article-title":"Histomorphometric assessment of bone mass, structure, and remodeling: a comparison between healthy black and white premenopausal women","volume":"12","author":"Parisien","year":"1997","journal-title":"J Bone Miner Res."},{"issue":"2","key":"2024020318273840300_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S8756-3282(99)00257-4","article-title":"Normative data for iliac bone histomorphometry in growing children","volume":"26","author":"Glorieux","year":"2000","journal-title":"Bone."},{"issue":"5","key":"2024020318273840300_bib16","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1359\/jbmr.081233","article-title":"PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation","volume":"24","author":"Theman","year":"2009","journal-title":"J Bone Miner Res."},{"issue":"1","key":"2024020318273840300_bib17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bone.2008.09.019","article-title":"Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1\u201384","volume":"44","author":"Recker","year":"2009","journal-title":"Bone."},{"issue":"2","key":"2024020318273840300_bib18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s00223-011-9500-6","article-title":"Teriparatide in bisphosphonate-resistant osteoporosis: microarchitectural changes and clinical results after 6 and 18 months","volume":"89","author":"Jobke","year":"2011","journal-title":"Calcif Tissue Int."},{"issue":"19","key":"2024020318273840300_bib19","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med."},{"issue":"10","key":"2024020318273840300_bib20","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1359\/jbmr.2001.16.10.1846","article-title":"Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study","volume":"16","author":"Dempster","year":"2001","journal-title":"J Bone Miner Res."},{"issue":"3","key":"2024020318273840300_bib21","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1210\/jc.2002-021988","article-title":"Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment","volume":"88","author":"Misof","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"2024020318273840300_bib22","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1210\/jc.2008-2630","article-title":"Effects of teriparatide treatment and discontinuation in postmenopausal women and eugonadal men with osteoporosis","volume":"94","author":"Leder","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2024020318273840300_bib23","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/jama.280.12.1067","article-title":"Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1-34): a randomized controlled trial","volume":"280","author":"Finkelstein","year":"1998","journal-title":"JAMA."},{"issue":"6","key":"2024020318273840300_bib24","first-page":"1617","article-title":"Bone mineral density in patients with chronic hypoparathyroidism","volume":"76","author":"Abugassa","year":"1993","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2024020318273840300_bib25","first-page":"3480","article-title":"A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism","volume":"83","author":"Winer","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2024020318273840300_bib26","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1210\/jc.2007-2552","article-title":"Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism","volume":"93","author":"Winer","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2024020318273840300_bib27","first-page":"391","article-title":"Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism","volume":"97","author":"Winer","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2024020318273840300_bib28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bone.2007.04.197","article-title":"Effects of daily treatment with parathyroid hormone 1\u201384 for 16 months on density, architecture and biomechanical properties of cortical bone in adult ovariectomized rhesus monkeys","volume":"41","author":"Fox","year":"2007","journal-title":"Bone."},{"issue":"6","key":"2024020318273840300_bib29","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.bone.2005.03.003","article-title":"Effects of teriparatide [rhPTH (1-34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women","volume":"36","author":"Uusi-Rasi","year":"2005","journal-title":"Bone."},{"issue":"10","key":"2024020318273840300_bib30","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1359\/jbmr.1999.14.10.1672","article-title":"A six-year longitudinal study of the relationship of physical activity to bone mineral accrual in growing children: the university of Saskatchewan bone mineral accrual study","volume":"14","author":"Bailey","year":"1999","journal-title":"J Bone Miner Res."},{"issue":"7","key":"2024020318273840300_bib31","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/jbmr.46","article-title":"Rapid growth produces transient cortical weakness: a risk factor for metaphyseal fractures during puberty","volume":"25","author":"Wang","year":"2010","journal-title":"J Bone Miner Res."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.1627","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/27\/8\/1811\/56560424\/1627_ftp.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/27\/8\/1811\/56560424\/1627_ftp.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:46:36Z","timestamp":1710341196000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/27\/8\/1811-1820\/7598283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,10]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2012,4,10]]},"published-print":{"date-parts":[[2012,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.1627","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,8,1]]},"published":{"date-parts":[[2012,4,10]]}}}